Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the highest quintile among peers.
Dunham Large Cap Value N DNLVX
- NAV / 1-Day Return 19.31 / +0.36 %
- Total Assets 156.5 Mil
-
Adj. Expense Ratio
- Expense Ratio 1.040%
- Distribution Fee Level High
- Share Class Type Institutional
- Category Large Value
- Investment Style Large Value
- Min. Initial Investment 100,000
- Status Open
- TTM Yield 1.17%
- Turnover 29%
USD | NAV as of Mar 28, 2024 | 1-Day Return as of Mar 28, 2024, 10:12 PM GMT+0
Morningstar’s Analysis DNLVX
Will DNLVX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 22.3
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
JPMorgan Chase & Co | 3.10 | 4.5 Mil | Financial Services |
Exxon Mobil Corp | 2.97 | 4.3 Mil | Energy |
Merck & Co Inc | 2.54 | 3.7 Mil | Healthcare |
Invesco Shrt-Trm Inv Treasury Instl | 2.45 | 3.6 Mil | Cash and Equivalents |
Abbott Laboratories | 2.43 | 3.5 Mil | Healthcare |
Berkshire Hathaway Inc Class B | 1.99 | 2.9 Mil | Financial Services |
Mondelez International Inc Class A | 1.93 | 2.8 Mil | Consumer Defensive |
Procter & Gamble Co | 1.88 | 2.7 Mil | Consumer Defensive |
Bank of America Corp | 1.87 | 2.7 Mil | Financial Services |
Thermo Fisher Scientific Inc | 1.85 | 2.7 Mil | Healthcare |